Key Statistics
Market Cap$280.89M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.88
52W High$4.00
52W Low$1.43
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees—
Price Performance
1 Week+2.22%
3 Month-21.59%
1 Year+55.93%
About
AC Immune SA, a clinical-stage biopharmaceutical company, discovers, designs and develops drugs and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company is headquartered in Lausanne, Switzerland.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze ACIU with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.